{"title":"Aspects of the biogenic amine-depleting activity of ethyl 3-acetamido-4H-pyrrolo-[3,4-c]isoxazole-5(6H)-carboxylate in the rat.","authors":"W Lippmann, M Wishnick","doi":"10.1111/j.1476-5381.1968.tb00987.x","DOIUrl":null,"url":null,"abstract":"Agents have been found which cause marked lowering of the catecholamine and/or 5-hydroxytryptamine concentrations in tissues and some (for example, a-methyldihydroxyphenylalanine, guanethidine and reserpine) are useful in the treatment of hypertension (Hafkenschiel & Sellers, 1954; Richardson & Wyso, 1959; Hollander, 1961; Page, Hurley & Dustan, 1961; Gillespie, Oates, Crout & Sjoerdsma, 1962; Cannon, Whitlock, Morris, Angers & Laragh, 1962). Ethyl 3-acetamido-4H-pyrrolo[3,4-c]isoxazole-5(6H)-carboxylate (CL-62375) has been reported to decrease both the catecholamine and 5-hydroxytryptamine concentrations in tissues of the rat (Lippmann & Wishnick, 1967). After a single administration of CL-62375 there is an appreciable lowering of the catecholamine concentration in the heart and brain and a slight fall in brain 5-hydroxytryptamine. After repeated administration of CL-62375 the heart shows the largest decrease in the catecholamine concentration followed by the brain and the adrenals; the brain 5-hydroxytryptamine decreases appreciably. CL-62375 causes a lowering of blood pressure in the rat (Cummings & Welter, 1967, personal communication). Studies on the mechanism of the biogenic amine-depleting activity of CL-62375 were carried out and the results are presented in the present paper.","PeriodicalId":9255,"journal":{"name":"British journal of pharmacology and chemotherapy","volume":"33 2","pages":"257-65"},"PeriodicalIF":0.0000,"publicationDate":"1968-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1476-5381.1968.tb00987.x","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British journal of pharmacology and chemotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/j.1476-5381.1968.tb00987.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Agents have been found which cause marked lowering of the catecholamine and/or 5-hydroxytryptamine concentrations in tissues and some (for example, a-methyldihydroxyphenylalanine, guanethidine and reserpine) are useful in the treatment of hypertension (Hafkenschiel & Sellers, 1954; Richardson & Wyso, 1959; Hollander, 1961; Page, Hurley & Dustan, 1961; Gillespie, Oates, Crout & Sjoerdsma, 1962; Cannon, Whitlock, Morris, Angers & Laragh, 1962). Ethyl 3-acetamido-4H-pyrrolo[3,4-c]isoxazole-5(6H)-carboxylate (CL-62375) has been reported to decrease both the catecholamine and 5-hydroxytryptamine concentrations in tissues of the rat (Lippmann & Wishnick, 1967). After a single administration of CL-62375 there is an appreciable lowering of the catecholamine concentration in the heart and brain and a slight fall in brain 5-hydroxytryptamine. After repeated administration of CL-62375 the heart shows the largest decrease in the catecholamine concentration followed by the brain and the adrenals; the brain 5-hydroxytryptamine decreases appreciably. CL-62375 causes a lowering of blood pressure in the rat (Cummings & Welter, 1967, personal communication). Studies on the mechanism of the biogenic amine-depleting activity of CL-62375 were carried out and the results are presented in the present paper.